Experienced in Endometrial Polyps

Dr. Nicholas P. Taylor

Gynecologic Oncology | Oncology | Obstetrics and Gynecology
St Lukes Physician Group Inc
1872 St Lukes Blvd, 
Easton, PA 
Offers Telehealth
Experienced in Endometrial Polyps
St Lukes Physician Group Inc
1872 St Lukes Blvd, 
Easton, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Nicholas Taylor is a Gynecologic Oncologist and an Oncologist in Easton, Pennsylvania. Dr. Taylor is rated as an Experienced provider by MediFind in the treatment of Endometrial Polyps. His top areas of expertise are Vulvar Cancer, Endometrial Cancer, Endometrial Stromal Sarcoma, Oophorectomy, and Hysterectomy.

His clinical research consists of co-authoring 13 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gynecologic Oncology
Oncology
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in NJ
Hospital Affiliations
St Luke's Hospital Bethlehem
St Lukes Quakertown Hospital
St Luke's Warren Hospital
St Luke's Hospital - Anderson Campus
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

ST LUKES PHYSICIAN GROUP INC
1872 St Lukes Blvd, Easton, PA 18045
Other Locations
ST LUKES PHYSICIAN GROUP INC
1736 W Hamilton St, Allentown, PA 18104
ST LUKES PHYSICIAN GROUP INC
701 Ostrum St, Fountain Hill, PA 18015
ST LUKES PHYSICIAN GROUP INC
1021 Park Ave, Quakertown, PA 18951
ST LUKES PHYSICIAN GROUP INC
3000 St Lukes Dr, Quakertown, PA 18951

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 01, 2025
Intervention Type: Drug, Procedure, Other
Study Drugs: Carboplatin, Cediranib Maleate, Gemcitabine, Gemcitabine Hydrochloride, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride
Study Phase: Phase 3
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Atezolizumab, Bevacizumab, Pegylated liposomal doxorubicin hydrochloride
Study Phase: Phase 2/Phase 3
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
Enrollment Status: Active_not_recruiting
Publish Date: September 16, 2025
Intervention Type: Procedure, Drug, Other
Study Drugs: Cediranib, Cediranib Maleate, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Topotecan, Topotecan Hydrochloride
Study Phase: Phase 2/Phase 3
Phase II Randomized Trial of Nivolumab With or Without Ipilimumab in Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase II Randomized Trial of Nivolumab With or Without Ipilimumab in Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Enrollment Status: Completed
Publish Date: August 29, 2025
Intervention Type: Biological
Study Phase: Phase 2
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Cisplatin
Study Phase: Phase 3
A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
A Randomized, Controlled, Double-Arm, Double-Blind, Multi-Center Study of Ofranergene Obadenovec (VB-111) Combined With Paclitaxel vs. Paclitaxel Combined With Placebo for the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Enrollment Status: Completed
Publish Date: January 10, 2023
Intervention Type: Drug
Study Drugs: VB-111, Paclitaxel
Study Phase: Phase 3
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Enrollment Status: Completed
Publish Date: November 07, 2022
Intervention Type: Other, Drug, Radiation
Study Drugs: Carboplatin, Cisplatin, Paclitaxel
Study Phase: Phase 3
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Enrollment Status: Completed
Publish Date: September 01, 2022
Intervention Type: Other
View 7 Less Clinical Trials

13 Total Publications

Case report and review of the literature regarding management of primary uterine primitive neuroectodermal tumors (PNET).
Case report and review of the literature regarding management of primary uterine primitive neuroectodermal tumors (PNET).
Journal: Gynecologic oncology reports
Published: March 20, 2025
Similar Doctors
Distinguished in Endometrial Polyps
Dr. Robert J. Rubino
Obstetrics and Gynecology
Distinguished in Endometrial Polyps
Dr. Robert J. Rubino
Obstetrics and Gynecology

Regional Womens Health Group LLC

101 Old Short Hills Rd, Suite 101, 
West Orange, NJ 
 (52.2 miles away)
973-736-1100
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Robert Rubino is an Obstetrics and Gynecologist in West Orange, New Jersey. Dr. Rubino is rated as a Distinguished provider by MediFind in the treatment of Endometrial Polyps. His top areas of expertise are Uterine Fibroids, Neonatal Ovarian Cyst, Ovarian Cysts, Angiomyoma, and Intrauterine Device Insertion. Dr. Rubino is currently accepting new patients.

Inna Tubman
Advanced in Endometrial Polyps
Dr. Inna Tubman
Obstetrics and Gynecology
Advanced in Endometrial Polyps
Dr. Inna Tubman
Obstetrics and Gynecology
4360 Hylan Boulevard, 
Staten Island, NY 
 (58.6 miles away)
718-818-4360
Languages Spoken:
English
See accepted insurances

Inna Tubman is an Obstetrics and Gynecologist in Staten Island, New York. Dr. Tubman is rated as a Distinguished provider by MediFind in the treatment of Endometrial Polyps. Her top areas of expertise are Angiomyoma, Uterine Fibroids, Neonatal Ovarian Cyst, Hormone Replacement Therapy (HRT), and Intrauterine Device Insertion.

Advanced in Endometrial Polyps
Dr. Allison R. Wagreich
Gynecologic Oncology | Obstetrics and Gynecology | Oncology
Advanced in Endometrial Polyps
Dr. Allison R. Wagreich
Gynecologic Oncology | Obstetrics and Gynecology | Oncology

Practice Associates Medical Group

100 Madison Ave, 
Morristown, NJ 
 (44.1 miles away)
973-971-5596
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Allison Wagreich is a Gynecologic Oncologist and an Obstetrics and Gynecologist in Morristown, New Jersey. Dr. Wagreich is rated as a Distinguished provider by MediFind in the treatment of Endometrial Polyps. Her top areas of expertise are Endometrial Cancer, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Oophorectomy, and Hysterectomy. Dr. Wagreich is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Taylor's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 15 Advanced Conditions
    View All 25 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile